Reprogramming the Tumor Microenvironment to Improve Immunotherapy: Emerging Strategies and Combination Therapies DOI
Meenal Datta, Lisa M. Coussens, Hiroyoshi Nishikawa

et al.

American Society of Clinical Oncology Educational Book, Journal Year: 2019, Volume and Issue: 39, P. 165 - 174

Published: May 1, 2019

Emerging immunotherapeutic approaches have revolutionized the treatment of multiple malignancies. Immune checkpoint blockers (ICBs) enabled never-before-seen success rates in durable tumor control and enhanced survival benefit patients with advanced cancers. However, this effect is not universal, resulting responder nonresponder populations only between, but also within solid types. Although ICBs are thought to be most effective against tumors more genetic mutations higher antigen loads, always case for all cancers or a cancer subtype. Furthermore, debilitating sometimes deadly immune-related adverse events (irAEs) resulted from aberrant activation T-cell responses following immunotherapy. Thus, we must identify new ways overcome resistance ICB-based immunotherapies limit irAEs. In fact, preclinical clinical data identified abnormalities microenvironment (TME) that can thwart efficacy such as ICBs. Here, will discuss how reprogramming various facets TME (blood vessels, myeloid cells, regulatory T cells [Tregs]) may TME-instigated mechanisms We applications strategic approach, including recent successful phase III trial combining bevacizumab atezolizumab chemotherapy metastatic nonsquamous non-small cell lung led rapid approval by U.S. Food Drug Administration regimen first-line treatment. Given accelerated testing combined targeted therapies larger numbers cancer, these concepts incorporated into practice improve immunotherapy outcomes.

Language: Английский

Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance DOI
Philip C. Calder

Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, Journal Year: 2014, Volume and Issue: 1851(4), P. 469 - 484

Published: Aug. 20, 2014

Language: Английский

Citations

1438

Gut Microbiota-Derived Short-Chain Fatty Acids, T Cells, and Inflammation DOI Creative Commons
Chang H. Kim, Jeongho Park, Myunghoo Kim

et al.

Immune Network, Journal Year: 2014, Volume and Issue: 14(6), P. 277 - 277

Published: Jan. 1, 2014

T cells are central players in the regulation of adaptive immunity and immune tolerance.In periphery, cell differentiation for maturation effector function is regulated by a number factors.Various factors such as antigens, co-stimulation signals, cytokines regulate into functionally specialized regulatory cells.Other nutrients, micronutrients, nuclear hormones microbial products provide important environmental cues differentiation.A mounting body evidence indicates that metabolites shortchain fatty acids (SCFAs) have profound effects on directly indirectly their differentiation.We review current status our understanding SCFA functions peripheral activity discuss impact tissue inflammation.

Language: Английский

Citations

564

Sepsis-induced immune dysfunction: can immune therapies reduce mortality? DOI Open Access
Matthew J. Delano, Peter A. Ward

Journal of Clinical Investigation, Journal Year: 2016, Volume and Issue: 126(1), P. 23 - 31

Published: Jan. 3, 2016

Sepsis is a systemic inflammatory response induced by an infection, leading to organ dysfunction and mortality. Historically, sepsis-induced lethality were attributed the interplay between antiinflammatory responses. With advances in intensive care management goal-directed interventions, early sepsis mortality has diminished, only surge later after "recovery" from acute events, prompting search for alterations immune function. well known alter innate adaptive responses sustained periods clinical "recovery," with immunosuppression being prominent example of such alterations. Recent studies have centered on immune-modulatory therapy. These efforts are focused defining reversing persistent cell that associated long events resolved.

Language: Английский

Citations

555

The multifaceted role of CD4+ T cells in CD8+ T cell memory DOI
Brian J. Laidlaw, Joseph Craft,

Susan M. Kaech

et al.

Nature reviews. Immunology, Journal Year: 2016, Volume and Issue: 16(2), P. 102 - 111

Published: Jan. 19, 2016

Language: Английский

Citations

547

The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue–resident regulatory T cells DOI
Ajithkumar Vasanthakumar, Kazuyo Moro, Annie Xin

et al.

Nature Immunology, Journal Year: 2015, Volume and Issue: 16(3), P. 276 - 285

Published: Jan. 19, 2015

Language: Английский

Citations

501

Development and maintenance of intestinal regulatory T cells DOI
Takeshi Tanoue, Koji Atarashi, Kenya Honda

et al.

Nature reviews. Immunology, Journal Year: 2016, Volume and Issue: 16(5), P. 295 - 309

Published: April 18, 2016

Language: Английский

Citations

491

Single-Cell Transcriptomics of Regulatory T Cells Reveals Trajectories of Tissue Adaptation DOI Creative Commons
Ricardo J. Miragaia, Tomás Gomes,

Agnieszka Chomka

et al.

Immunity, Journal Year: 2019, Volume and Issue: 50(2), P. 493 - 504.e7

Published: Feb. 1, 2019

Non-lymphoid tissues (NLTs) harbor a pool of adaptive immune cells with largely unexplored phenotype and development. We used single-cell RNA-seq to characterize 35,000 CD4+ regulatory (Treg) memory (Tmem) T in mouse skin colon, their respective draining lymph nodes (LNs) spleen. In these tissues, we identified Treg cell subpopulations distinct degrees NLT phenotype. Subpopulation pseudotime ordering gene kinetics were consistent recruitment yet the initial NLT-priming LNs final stages functional adaptation reflected tissue-specific differences. Predicted recapitulated using an vivo melanoma-induction model, validating key regulators receptors. Finally, profiled human blood Tmem cells, cross-mammalian conserved tissue signatures. summary, describe relationship between heterogeneity NLTs through combined use computational prediction validation.

Language: Английский

Citations

437

Helper T cell differentiation DOI Open Access
Jordy Saravia, Nicole M. Chapman, Hongbo Chi

et al.

Cellular and Molecular Immunology, Journal Year: 2019, Volume and Issue: 16(7), P. 634 - 643

Published: March 12, 2019

Citations

398

Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis DOI
Jun Wei, Lingyun Long, Kai Yang

et al.

Nature Immunology, Journal Year: 2016, Volume and Issue: 17(3), P. 277 - 285

Published: Jan. 25, 2016

Language: Английский

Citations

393

Foxp3+ T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation DOI Creative Commons
Bi-Huei Yang,

Stefanie Hagemann,

Panagiota Mamareli

et al.

Mucosal Immunology, Journal Year: 2015, Volume and Issue: 9(2), P. 444 - 457

Published: Aug. 26, 2015

Language: Английский

Citations

365